Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Meng‐Yao Xu"'
Autor:
Qi-Dong Xia, Jian-Xuan Sun, Zhi-Peng Yao, Jun-Lin Lu, Chen-Qian Liu, Jin-Zhou Xu, Ye An, Meng-Yao Xu, Si-Han Zhang, Xing-Yu Zhong, Na Zeng, Si-Yang Ma, Hao-Dong He, Heng-Long Hu, Jia Hu, Yi Lu, Bing Li, Yao-Bing Chen, Zheng Liu, Shao-Gang Wang
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract We aimed to investigate the genomic and tumor microenvironmental (TME) profiles in non-muscle invasive bladder cancer (NMIBC) and explore potential predictive markers for Bacillus Calmette–Guérin (BCG) treatment response in high-risk NMIB
Externí odkaz:
https://doaj.org/article/dc4bb2721ff94fe1a81803c0f0ae0d34
Autor:
Meng-Yao Xu, Na Zeng, Chen-Qian Liu, Jian-Xuan Sun, Ye An, Si-Han Zhang, Jin-Zhou Xu, Xing-Yu Zhong, Si-Yang Ma, Hao-Dong He, Jia Hu, Qi-Dong Xia, Shao-Gang Wang
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-23 (2024)
Abstract Enhanced cellular therapy has emerged as a novel concept following the basis of cellular therapy. This treatment modality applied drugs or biotechnology to directly enhance or genetically modify cells to enhance the efficacy of adoptive cell
Externí odkaz:
https://doaj.org/article/8ad6007f8ff74808b59c24c681dc65df
Autor:
Meng-Yao Xu, Zhi-Yu Xia, Jian-Xuan Sun, Chen-Qian Liu, Ye An, Jin-Zhou Xu, Si-Han Zhang, Xing-Yu Zhong, Na Zeng, Si-Yang Ma, Hao-Dong He, Shao-Gang Wang, Qi-Dong Xia
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The emergence of resistance to prostate cancer (PCa) treatment, particularly to androgen deprivation therapy (ADT), has posed a significant challenge in the field of PCa management. Among the therapeutic options for PCa, radiotherapy, chemotherapy, a
Externí odkaz:
https://doaj.org/article/794a642116d4478eaed39e3690b6ce14
Autor:
Jin-Zhou Xu, Qi-Dong Xia, Jian-Xuan Sun, Chen-Qian Liu, Jun-Lin Lu, Meng-Yao Xu, Ye An, Yang Xun, Zheng Liu, Jia Hu, Cong Li, Shao-Gang Wang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract Pyroptosis is a type of programmed cell death and plays a dual role in distinct cancers. It is elusive to evaluate the activation level of pyroptosis and to appraise the involvement of pyroptosis in the occurrence and development of diverse
Externí odkaz:
https://doaj.org/article/c482d20abb0e4affaa25ad595e382e6f
Autor:
Si-Yang Ma, Ye An, Jian-Xuan Sun, Meng-Yao Xu, Chen-Qian Liu, Jin-Zhou Xu, Xing-Yu Zhong, Na Zeng, Hao-Dong He, Qi-Dong Xia, Shao-Gang Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
HighlightsThis meta-analysis and systematic review aim to analyze the association between BT and oncological outcomes of patients undergoing RC for bladder cancer, and tries to find out whether the timing of blood transfusion could also have an effec
Externí odkaz:
https://doaj.org/article/2acf986aa0494cfbb35919efb8ae9478
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe high recurrence rate of non-muscle-invasive bladder cancer (NMIBC) after tumor resection brings huge physical and financial burdens for patients. Several predictive models that predict the recurrence of patients with NMIBC have drawback
Externí odkaz:
https://doaj.org/article/f537e1f068f04caa97b4fc7ae3f0b5cf
Autor:
Si-Han Zhang, Na Zeng, Jian-Xuan Sun, Chen-Qian Liu, Jin-Zhou Xu, Meng-Yao Xu, Ye An, Xing-Yu Zhong, Si-Yang Ma, Hao-Dong He, Qi-Dong Xia, Jia Hu, Shao-Gang Wang
Publikováno v:
Heliyon, Vol 9, Iss 6, Pp e16644- (2023)
Background: Cereblon (CRBN) has emerged as a vital E3 ubiquitin ligase for Proteolysis-targeting chimera (PROTAC) design. However, few studies focus on the physiological mechanism of CRBN, and more studies are needed to explore the influence of CRBN
Externí odkaz:
https://doaj.org/article/d0a70bc1f0554f0da64992375c7f32bf
Autor:
Na Zeng, Meng-Yao Xu, Jian-Xuan Sun, Chen-Qian Liu, Jin-Zhou Xu, Ye An, Xing-Yu Zhong, Si-Yang Ma, Hao-Dong He, Qi-Dong Xia, Shao-Gang Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionWith the shortage of bacillus Calmette–Guérin (BCG) vaccine, it is important to find an alternative to BCG instillation, which is the most commonly used adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC) patients after
Externí odkaz:
https://doaj.org/article/23eca6c816294f0ab40a341a7be893cc
Autor:
Qi-Dong Xia, Bo Li, Jian-Xuan Sun, Chen-Qian Liu, Jin-Zhou Xu, Ye An, Meng-Yao Xu, Si-Han Zhang, Xing-Yu Zhong, Na Zeng, Si-Yang Ma, Hao-Dong He, Yu-Cong Zhang, Wei Guan, Heng Li, Shao-Gang Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundT cell immunoglobulin and ITIM domain (TIGIT) is a widely concerned immune checkpoint, which plays an essential role in immunosuppression and immune evasion. However, the role of TIGIT in normal organ tissues and renal clear cell carcinoma
Externí odkaz:
https://doaj.org/article/e1b5833590724c818692a9377361a84a
Autor:
Ye An, Jian-Xuan Sun, Meng-Yao Xu, Jin-Zhou Xu, Si-Yang Ma, Chen-Qian Liu, Zheng Liu, Shao-Gang Wang, Qi-Dong Xia
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundTertiary lymphoid structures (TLSs) are emerging as a potential predictor of prognosis and response to immunotherapy in some solid tumors. However, the comprehensive role of TLSs in bladder cancer remains unclear.MethodsEighteen bladder can
Externí odkaz:
https://doaj.org/article/8b612914fe8942cb8a8047f06dd8a865